Acquisition of Fluticasone Furoate + Vilanterol

This tender, issued by HTAL. ABEL ZUBIZARRETA, is for the acquisition of a specific pharmaceutical product: Fluticasone Furoate + Vilanterol. The medication is described as a powder for inhalation, with each unit containing 92 mcg of fluticasone furoate and 22 mcg of vilanterol. The quantity required is 180 units, with an estimated cost of ARS 2,200.0. This is a minor procurement contract categorized under Health. This medication is typically used for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), providing bronchodilation and anti-inflammatory effects. The tender highlights the hospital's need to maintain a supply of essential respiratory medications for patient care.

This is a works contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Argentina, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of ARS 396,000.

Published through Buenos Aires Compras (BAC), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for civil works in the health and medical services sector. Works contracts of this nature generally require demonstrated experience in similar infrastructure projects, adequate equipment and technical personnel, and financial capacity including bank guarantees. This contract has already been awarded. The information is published for transparency and market intelligence purposes.